[Federal Register Volume 77, Number 103 (Tuesday, May 29, 2012)]
[Notices]
[Pages 31624-31625]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-12864]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Recombinant DNA Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Recombinant DNA Advisory Committee.
Date: June 19, 2012.
Time: 9:00 a.m. to 3:30 p.m.
Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will
discuss selected human gene transfer protocols. Please view the
meeting agenda at http://oba.od.nih.gov/rdna_rac/rac_meetings.html
for more information.
Place: National Institutes of Health, Building 31C, 9000
Rockville Pike, 6th Floor Conference Room, Rockville, MD 20892.
Contact Person: Chezelle George, Office of Biotechnology
Activities, Office of Science Policy/OD, National Institutes of
Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892, 301-496-
9838, [email protected].
OBA will again offer those members of the public viewing the
meeting via webcast (see OBA Meetings Page available at http://oba.od.nih.gov/rdna_rac/rac_meetings.html) the opportunity to
submit comments during the public comment periods. Individuals
wishing to submit comments should use the comment form, which will
accommodate comments up to 1500 characters, and will be available on
the OBA Web site during the meeting (see OBA Meetings Page). Please
limit your comments to a statement that can be read in one to two
minutes. Please include your name and affiliation with your comment.
Only comments submitted through the OBA Web site will be read.
OBA will read comments into the record during the public comment
periods as stated on the agenda. It is not unusual for the meeting
to run ahead or behind schedule due to changes in the time needed to
review a protocol. It is advisable to monitor the webcast to
determine when public comments will be read. Each public comment
period follows a specific discussion item. OBA will
[[Page 31625]]
read comments that are related to the protocol under discussion at
that time. General comments unrelated to the protocol or
presentation under discussion at that time. General comments
unrelated to a specific agenda item will be read at the end of the
meeting, time permitting. Comments submitted by email through the
OBA Web site will follow any comments by individuals attending the
meeting. Comments will be read in the order received and your name
and affiliation will be read with the comments. Please note OBA may
not be able to read every comment received in the time allotted for
public comment. Comments not read will become part of the public
record.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit. Information is also available on the Institute's/Center's
home page: http://oba.od.nih.gov/rdna/rdna.html, where an agenda and
any additional information for the meeting will be posted when
available.
OMB's ``Mandatory Information Requirements for Federal
Assistance Program Announcements'' (45 FR 39592, June 11, 1980)
requires a statement concerning the official government programs
contained in the Catalog of Federal Domestic Assistance. Normally
NIH lists in its announcements the number and title of affected
individual programs for the guidance of the public. Because the
guidance in this notice covers virtually every NIH and Federal
research program in which DNA recombinant molecule techniques could
be used, it has been determined not to be cost effective or in the
public interest to attempt to list these programs. Such a list would
likely require several additional pages. In addition, NIH could not
be certain that every Federal program would be included as many
Federal agencies, as well as private organizations, both national
and international, have elected to follow the NIH Guidelines. In
lieu of the individual program listing, NIH invites readers to
direct questions to the information address above about whether
individual programs listed in the Catalog of Federal Domestic
Assistance are affected.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: May 18, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-12864 Filed 5-25-12; 8:45 am]
BILLING CODE 4140-01-P